Therefore, the high level of leptin in obese patients is the main reason for tumor progression and metastasis, and increasing the circulating level of adiponectin in the body can break the tumor-promoting effect of leptin, especially supplementing sufficient adiponectin to obese tumor patients to reverse the series of cancer-promoting effects caused by the high concentration of leptin. Here, ADIPOQ is linked to cancer.